PMC:7358770 / 3588-3824 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T22","span":{"begin":148,"end":150},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma284995"},{"id":"A23","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma82837"}],"text":"d relevant structural features are highlighted as follows: N-terminal receptor binding domain (N-RBD) in dark blue; C-RBD in brown; cleavage sites (CS) 1 and 2, fusion peptide (FP) in red, heptad repeat (HR) regions 1 and 2 in green; tr"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T34","span":{"begin":168,"end":175},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"d relevant structural features are highlighted as follows: N-terminal receptor binding domain (N-RBD) in dark blue; C-RBD in brown; cleavage sites (CS) 1 and 2, fusion peptide (FP) in red, heptad repeat (HR) regions 1 and 2 in green; tr"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T36","span":{"begin":148,"end":150},"obj":"Chemical"},{"id":"T38","span":{"begin":168,"end":175},"obj":"Chemical"},{"id":"T39","span":{"begin":177,"end":179},"obj":"Chemical"}],"attributes":[{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_73462"},{"id":"A37","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_37397"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_74750"}],"text":"d relevant structural features are highlighted as follows: N-terminal receptor binding domain (N-RBD) in dark blue; C-RBD in brown; cleavage sites (CS) 1 and 2, fusion peptide (FP) in red, heptad repeat (HR) regions 1 and 2 in green; tr"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T106","span":{"begin":87,"end":93},"obj":"SO:0000417"},{"id":"T107","span":{"begin":132,"end":140},"obj":"MOP:0000780"},{"id":"T46400","span":{"begin":21,"end":30},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T99254","span":{"begin":52,"end":58},"obj":"NCBITaxon:3193"},{"id":"T58294","span":{"begin":76,"end":83},"obj":"NCBITaxon:33208"},{"id":"T73413","span":{"begin":118,"end":133},"obj":"CHEBI:18154;CHEBI:18154"}],"text":"d relevant structural features are highlighted as follows: N-terminal receptor binding domain (N-RBD) in dark blue; C-RBD in brown; cleavage sites (CS) 1 and 2, fusion peptide (FP) in red, heptad repeat (HR) regions 1 and 2 in green; tr"}